Page 2 - Kare Schultz News Today

The Israeli pharmaceutical company is to issue $2.06 billion of sustainability-linked senior notes and has begun tender offers to purchase up to $2.25 billion of notes.

Adderall, which treats attention-deficit/hyperactivity disorder and the sleep disorder narcolepsy, remains in short supply for over half a year.

Operator: I would like to welcome everyone to the IFF Fourth Quarter and Full Year 2022 Earnings Conference Call.

Teva's stock price dipped after the release of its 2022 financials, but analysts believe that a settlement in the opioids affair could trigger a comeback.

New Teva CEO Richard Francis: We continued to optimize our supply chain and manufacturing capabilities and reduced our net debt.

These profitable companies are exceptionally cheap and ripe for the picking, following a 33% decline in the Nasdaq Composite.

A 33% plunge in the Nasdaq Composite is the opportune time to scoop up these exceptional deals.

Richard Francis, who took over at the Teva helm less than two weeks ago, told the JP Morgan Healthcare Conference that he knew the company well as a competitor.

This mix of growth and value stocks can outperform in a challenging environment.

The number of people employed by drug company Teva in Israel has halved since 2012.